Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Giants running back Cam Skattebo apologized Saturday for the comments he made on CTE and asthma on a recent podcast appearance.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

SPOKANE, Wash. -- The Spokane Allergy & Asthma Clinic suddenly shut down its practice on Wednesday. In a post on Facebook, the clinic did not provide a reason for the closure. The clinic said it would ...

Use of single maintenance and reliever therapy (SMART) for moderate-to-severe asthma saved money by improving outcomes, according to a meta-analysis. While SMART is recommended by guidelines, ...

Asthma may not be driven by the molecules scientists have blamed for decades. Researchers have identified “pseudo leukotrienes,” inflammation-triggering compounds formed by uncontrolled free-radical ...

Please provide your email address to receive an email when new articles are posted on . Many parents believe children will outgrow wheeze without seeing a specialist. Many patients also underestimate ...

Researchers from UW-Milwaukee and UW-Madison are studying the link between air pollution and asthma-related school nurse visits at MPS. They'll use satellite data to estimate nitrogen dioxide levels ...

Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a different ...

The FDA has approved GSK’s anti-IL-5 antibody depemokimab for the treatment of severe eosinophilic asthma in patients 12 and older. The drug will carry the brand name Exdensur. Exdensur is indicated ...